ArticleScience (New York, N.Y.)2020
CRISPR-engineered T cells in patients with refractory cancer.
Edward A Stadtmauer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
876 papers cite itlatest 60 shown
this paperpooled ittrialcites it